Project Grant HT94252410740
Award Date
8/15/24
Completion Date
8/14/26
Dollars Obligated
$672K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The U.S. Department of Defense, through the Military Medical Research and Development (CFDA 12.420) program, awarded a $1,344,000.00 Project Grant to the Albert Einstein College of Medicine in Bronx, NY. The grant, with a performance period from May 1, 2025 to April 30, 2029, will fund research to target noncanonical Wnt signaling pathways in order to prevent metastases in Ewing sarcoma using a novel zebrafish model. As a prominent research institution, the Albert Einstein College of Medicine...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The Albert Einstein College of Medicine has been awarded a $168,000 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the role of alpha1-3/4 fucosyltransferases-mediated E-selectin function in the bone metastasis of prostate cancer. The project aims to advance scientific understanding and develop new treatment approaches for this form of cancer that disproportionately affects military service members...
The Department of the Army Medical Command awarded a $462,000.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Albert Einstein College of Medicine in Bronx, NY. The grant, with a performance period from January 1, 2025 to December 31, 2026, supports advanced biomedical research focused on the "Proteomics of Vascular Wall Aging." As a prominent research institution, the Albert Einstein College of Medicine will leverage its expertise in...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
This federal Project Grant award of $672,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Albert Einstein College of Medicine in Bronx, New York to investigate a novel synthetic lethal vulnerability that can be targeted by inhibiting one-carbon metabolism in anaplastic thyroid cancer. The research aims to advance scientific understanding and develop innovative medical solutions...
The Albert Einstein College of Medicine was awarded a $1,260,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support research into "A NOVEL IMMUNE CHECKPOINT PATHWAY IN HUMAN PROSTATE CANCER" from July 1, 2022 to June 30, 2025. The Military Medical Research and Development program aims to transform health care for service members and the public through innovative...
The Albert Einstein College of Medicine has been awarded a $882,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a novel targeted drug therapy to treat small cell lung cancer (SCLC). The award will support research activities from June 1, 2024 through May 31, 2027. As a highly experienced recipient of federal research grants and contracts, the college has a track record of conducting biomedical research and...
The Albert Einstein College of Medicine was awarded a $505,122 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to decipher the stemness code for breast cancer metastasis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health...